Dr. Lee has over 18 years of informatics expertise ranging from biomedical research in genomic cancer research, clinical trials, molecular pharmacology, psychiatric genetics, and bioinformatics. He has specialized technical expertise in data governance, big data visualization, enterprise BI analytics and using large-scale data warehouses.
His biomedical research experience focuses on profiling variants involved in disease classification, progression and prediction which aid in supporting clinical interpretation for Next Generation Sequencing applications.
Most recently, Dr. Lee leads strategy and technology selection with big pharma, mobile Health leaders, academic medical centers, providers, and payors. Specialties include data integration through advanced annotation, analysis, visualization and reporting. He has recently delivered these capabilities for federal and commercial health and life science organizations. His external activities include serving as an NIH grant reviewer for large multi-site initiatives. He recently published a chapter in the “2015 Health law and Compliance Update” distributed by Wolters Kluwer.